Nov 6, 2026
How to Choose the Right Liposomal NAD+ Powder Specification for Your Product
A liposomal NAD+ powder specification is easier to defend when it is written backwards. Start with the finished product rather than a supplier catalogue: how much powder one serving can carry, how much NAD+ the label declares, and what the manufacturing route does to the particles. Those three inputs set the load grade, and the grade then constrains almost everything else. The material discussed here is described on the liposomal NAD+ powder product page.
Why the Specification Should Follow the Product
A specification sheet describes a material; it does not make a decision. The same 50% grade can be right for one brand and wrong for another, because a grade only becomes meaningful once it is divided into a fill weight. Two products with identical claims can end up with fill weights four times apart, and that gap reaches capsule size, sachet dimensions, unit count per carton and line speed.
The order of decisions matters because each closes off the others. Change the fill weight after capsule tooling is ordered and the chain reopens: blend ratio, flow on the filler, tablet hardness where compression is used, and the stability protocol written around a particular mass.
The Three Inputs Behind Every Grade Decision
Three numbers are needed before a grade can be discussed, and none comes from a supplier. For background, see this overview of what liposomal NAD powder is and where it fits in wellness formats.
| Input | What it fixes | Where the number comes from |
|---|---|---|
| Single-serve fill weight | The denominator of the load calculation, and the space the powder must occupy | Capsule size class, sachet fill target, tablet weight |
| Label claim per serving | The numerator, and the figure that must still hold at end of shelf life | Label copy and the claim support file |
| Process route | How much shear, moisture and heat the particles will meet | Dry blend, roller compaction, wet granulation, direct compression |
A fourth input belongs in the same note: the overage policy. If the claim must hold at end of shelf life rather than at release, either use an end-of-life assay in the calculation or state an overage. Leaving it implicit is a common reason a sound formula fails a label check two years later.
Calculating the Load You Actually Need
The arithmetic is simple. Required load, as a percentage, equals the label claim per serving divided by the single-serve fill weight, multiplied by one hundred.
Take a sachet designed around a 1.90 g fill and a claim of 0.40 g of NAD+ per serving. The required load is 0.40 divided by 1.90, or 21.1%. The first available grade at or above that figure is 30%. Choosing 30% then changes the fill: to keep the claim exact, the fill becomes 0.40 divided by 0.30, or 1.33 g, which is 0.57 g lighter than the sachet was designed for. The 20% grade would need 2.00 g for the same claim, which overfills it.
That is the entire decision, which is why a grade cannot be chosen in isolation. Either the format moves to meet the grade, or the grade moves to meet the format. Rounding down is not an option: a 20% grade cannot meet a 21.1% requirement without a new fill weight, and shipping it unchanged overstates the label from the first lot.
| Nominal grade | Powder for a 0.40 g claim | Formats that can carry it | Formulation note |
|---|---|---|---|
| 10% | 4.00 g | Sachet or stick only | Large carrier share; suits a drink mix |
| 20% | 2.00 g | Stick pack, sachet | Easiest to distribute evenly |
| 30% | 1.33 g | Stick, small sachet, large tablet | Balances fill size and premix fraction |
| 40% | 1.00 g | Stick pack, tablet | Check tablet weight and hardness |
| 50% | 0.80 g | Two-piece capsule, small stick | Common default for capsule ranges |
| 60% | 0.67 g | Capsule | Blend uniformity needs attention |
| 70% | 0.57 g | Capsule, small formats | Thin phospholipid phase; flow and wetting change |
Why the Highest Available Grade Is Rarely the Answer
Specifying 70% as insurance misreads the number. At 70% the powder is mostly NAD+ and the phospholipid phase is thin, so the material doing the encapsulating has less mass to work with per gram. Encapsulation efficiency, wetting and flow become properties of the active rather than of a balanced system.
Blend uniformity is the first casualty. A high-load grade is used in smaller quantities, so it becomes a small mass fraction of the blend, and small fractions of a fine, dense powder are the hardest to distribute evenly. A 20% grade at 2 g per serving blends far more easily than a 70% grade at 0.57 g.
Flow follows. Fill weight variation on a sachet line is largely a flow property, and highly loaded liposomal powders tend to be finer, more cohesive and prone to bridging. A few percent of fill variation becomes a few percent of claim variation, lot after lot.
Capsule size is the third constraint, and the one buyers notice. A low grade forces more powder per unit and a larger capsule for the same claim, often discovered after marketing has fixed the size. Format trade-offs are set out in this comparison of powder and capsule presentations.
Encapsulation Efficiency Is a Method-Dependent Number
The band published for this material is 85% to 95%, and the figure is meaningless without the method attached to it. Encapsulation efficiency can mean encapsulated active divided by total active, or retention after a washing step, and the two definitions differ on the same lot. Ask which separation was used, whether the free fraction was measured directly or by difference, and at what dilution.
The practical issue is comparability. A dialysis measurement on a dilute dispersion and an ultrafiltration measurement on a concentrated one are not the same experiment, and the gap between them on one batch can exceed the gap between two production sites. The methods used for this material are described in this guide to testing liposomal NAD powder quality.
Particle Size: Ask Which Distribution You Are Being Shown
Dynamic light scattering returns an intensity-weighted result by default, and intensity weighting is dominated by the largest particles present because scattering scales with the sixth power of diameter. A small population of aggregates can move the reported mean while the bulk of the material is unchanged. Two reports that both read around 150 nm can describe different powders.
Ask for the distribution basis, intensity, volume or number, with the medium, temperature, dilution factor and equilibration time, and whether the value is a Z-average or a peak. A polydispersity index helps. For a freeze-dried powder the reconstitution protocol must be fixed too, or the number describes the resuspension rather than the product. The steps that create the particles are covered in this walkthrough of how liposomal NAD powder is made.
Heavy Metals, Moisture and Bioburden
The lead limit published for this product is below 0.1 ppm, tighter than the figure applied to most liposomal raw materials. A tight limit is only meaningful if the method supports it. Ask for ICP-MS data with the quantification limit stated, because a result below 0.1 ppm from a method whose LOQ is 0.5 ppm is not evidence of anything.
Microbial control follows the same logic: a total plate count ceiling below 1000 cfu/g, plus the absence tests that apply to a non-sterile dietary ingredient. Moisture and water activity deserve equal attention. A powder stored for up to 24 months is more often lost to caking and lipid oxidation than to contamination, as these notes on shelf life factors explain.
| Specification item | Why it matters in a formula | Evidence to request |
|---|---|---|
| NAD+ assay | The numerator of every label calculation | HPLC method, column, standard, lot result |
| Grade, 10% to 70% | Sets the fill weight for a given claim | Certificate stating grade and supporting assay |
| Encapsulation efficiency, 85% to 95% | How much active sits inside the bilayer | Definition, separation method, release and stability values |
| Particle size by DLS | Dispersibility, mouthfeel, fill behaviour | Distribution basis, medium, dilution, Z-average, PDI, TEM |
| Appearance, pale yellow to white | Batch consistency; darkening signals change | Colour description per lot, retained photo standard |
| Moisture and water activity | Drives caking and lipid oxidation | Karl Fischer or loss-on-drying result and limit |
| Dispersibility | Whether the powder wets out without lumps | A defined dispersion test, not a description |
| Lead, below 0.1 ppm | Tighter than most actives; must be demonstrated | ICP-MS report with LOQ and spike recovery |
| Total plate count, below 1000 cfu/g | A non-sterile powder still needs a bioburden ceiling | Micro panel, method, per-lot results |
| Certifications, eight listed | Market access and permitted label statements | Certificate copies with scope and expiry |
Change Control: What to Re-Validate When the Grade Changes
Changing grade, phospholipid source or drying route is not a like-for-like substitution, even when the new lot matches the old one on assay. Re-validate the points that depend on mass fraction and particle behaviour: blend uniformity at the new ratio, fill weight control, encapsulation efficiency at release and after three months, particle size after reconstitution, and the claim at end of shelf life, as outlined in this guide to NAD powder stability.
Ask for a change notification clause and a comparison lot before the switch. A new grade inside the assay specification but outside the particle size specification will disperse differently, and the difference surfaces in the finished product rather than the paperwork. The checks that catch it early are summarised in this guide to evaluating NAD powder quality.
A Decision Table for Common Product Formats
Read each row left to right: the finished-product requirement, the grade that satisfies it, and the constraint that produced the answer.
| Finished-product input | Grade to specify | Why this grade |
|---|---|---|
| Capsule line, 0.25 g claim, fill capped near 0.60 g | 50% | Only closes at high load; capsule volume is the binding constraint |
| Capsule, 0.20 g claim, size not yet fixed | 40% | Leaves room to step down a capsule size |
| Stick pack, 2 g fill target, 0.40 g claim | 20% | 2.00 g meets the claim exactly; fill target unchanged |
| Stick pack, 1.5 g fill, 0.30 g claim | 20% | 1.50 g fits; a lower grade pushes past the stick |
| Drink mix sachet, 0.30 g claim, fill unconstrained | 10% to 20% | Larger carrier share disperses more readily in a flavoured system |
| Direct-compression tablet, 0.30 g claim in 1.0 g | 30% | 1.00 g meets the claim; verify flow and hardness |
| Multi-active blend, 0.15 g claim, premix diluted further | 30% to 40% | Keeps the premix fraction high enough to blend evenly |
What to Request With a Sample
A grade on its own is not a specification. A sample should arrive with a lot-specific certificate, a specification sheet stating ranges rather than single values, the encapsulation efficiency method and its definition, a DLS report with distribution basis and medium, ICP-MS data for lead with the quantification limit, a micro panel, copies of the eight certificates with scope and expiry, and a stability summary. This guide to what a NAD certificate of analysis should contain lists the fields worth checking.
EmerWell supplies liposomal NAD+ powder across the 10% to 70% range with 50% as the common default, and supports grade selection by running the fill-weight arithmetic against your claim and format. Dispersion trials, particle size re-measurement in your own medium and a certificate format review can be arranged through the NAD+ raw material page or by writing to info@emerwell-bio.com.
References
- U.S. Food and Drug Administration, 21 CFR Part 111, Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. ecfr.gov
- U.S. Food and Drug Administration, Dietary Supplements. fda.gov
- European Food Safety Authority, Nutrition and Health Claims. efsa.europa.eu
- U.S. Pharmacopeia, general chapters and reference standards for dietary supplements. usp.org
Disclaimer: This article is written for formulators, quality managers and procurement teams evaluating raw materials. It is not medical or nutritional advice and makes no claim about any finished product. The specifications quoted are those published on the EmerWell product page for liposomal NAD+ powder; lot-specific values are stated on the certificate of analysis.
Online Message